🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This prospective cohort study is part of the Clinnova programme and aims to...
Status
Recruiting
Location
Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB)
Start Date
2024-12-10
Trial ID
NCT06526364
Treatments Being Tested
The purpose of this study is to make a bar from the soy-protein Russian Tar...
Status
Completed
Location
Pennington Biomedical Research Center
Start Date
2021-10-25
Trial ID
NCT05130593
Treatments Being Tested
A total of 22 subjects will be included in the study. The subjects who were...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-12
Trial ID
NCT06557447
The purpose of this study is to examine the agreement between venous blood ...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT00569634
Treatments Being Tested
This study is a prospective study aimed to validate the performance of comb...
Status
Unknown
Location
Fudan university shanghai cancer center, Deparment of gynecologic oncology
Start Date
2023-02-22
Trial ID
NCT06001099
Currently, one of the main health challenges of public health is to improve...
Status
Completed
Location
Basque Culinary Center Fundazioa
Start Date
2021-05-26
Trial ID
NCT04908163
This is an ancillary laboratory study to collect and bank blood and tissue ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04
Trial ID
NCT07550049
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
This study plans to learn more about people who are sick in the hospital wi...
Status
Recruiting
Location
University of Colorado Hospital
Start Date
2014-11
Trial ID
NCT02299921
Treatments Being Tested
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested